In this presentation, IHS HOPE Committee members LCDR Kristin Allmaras, PharmD, BCACP and CDR Tana Triepke, PharmD, BCACP, AE-C, TTS share information on naloxone. They discuss promising practices, how to… […]
Audience: Clinical
Harm Reduction Works | November 2, 2021
In this presentation, Jess Tilley shares the Harm Reduction Works history and reviews the Harm Reduction Works Host Script (HRH413). […]
Sample CPA (BOP)
Sample Collaborative Practice Agreement (CPA) for Pharmacy Delivered Patient Care Services, including Diabetes, Hepatitis C, and Medication-Assisted Treatment within the Federal Bureau of Prisons (BOP) […]
Detection of Impaired Cognition Which has Impact on Function (Dementia): Earlier is Better! | October 28, 2021
Early detection of impaired cognition can slow progression and improve function in Alzheimer’s disease and other kinds of progressive dementia, help persons living with dementia and their family to prepare… […]
Fentanyl’s Rising Presence in Oregon | October 27, 2021
In this presentation, guests from Overdose Data to Action: Oregon HOPE discuss the rising prevalence of fentanyl in substances used, share insight from interviews with persons who are currently exposed… […]
Read More… from Fentanyl’s Rising Presence in Oregon | October 27, 2021
HIV Care and Sexual Health Assessment for American Indian and Alaska Native Patients (UIHI)
Explore best practices in inclusive sexual health assessment and HIV care. This course is made for health professionals who provide medical care to American Indian and Alaska Native patients. All modules… […]
Managing Latent TB for the I/T/U Provider | October 21, 2021
In this series of presentations, Dr. Jonathan Iralu, Chief Clinical Consultant for Infectious Diseases at IHS, provides a clinical update on emerging COVID-19 topics. Then, Dr. Marcos Burgos, associate professor… […]
Read More… from Managing Latent TB for the I/T/U Provider | October 21, 2021
Kratom | October 7, 2021
In this presentation, Dr. Jonathan Robbins discusses the substance Kratom, outlines the dangers of Kratom Use Disorder, and addresses evidence based treatment options. […]
Fentanyl’s Rising Presence in Oregon | October 5, 2021
In this presentation, guests from Overdose Data to Action: Oregon HOPE discuss the rising prevalence of fentanyl in substances used, share insight from interviews with persons who are currently exposed… […]
Read More… from Fentanyl’s Rising Presence in Oregon | October 5, 2021
Timing and Cognitive Screening – Big Picture | October 14, 2021
Dementia, of all kinds, occurs in all communities and is a chronic disease. With the proper tools and education, it can be diagnosed and managed, for the most part, in… […]
Read More… from Timing and Cognitive Screening – Big Picture | October 14, 2021